Journal article
Effect of L-leucine on oral melphalan kinetics in patients
PA Reece, BM Dale, RG Morris, D Kotasek, D Gee, S Rogerson
Cancer Chemotherapy and Pharmacology | SPRINGER | Published : 1987
DOI: 10.1007/BF00570497
Abstract
Melphalan uptake in the intestine has recently been shown to be an energy-dependent process which is affected by metabolic inhibitors. It is therefore theoretically possible that amino acids in food could reduce melphalan absorption by competing for uptake at the sites of absorption in the intestine. Since L-leucine has been shown to be the most potent inhibitor of melphalan transport into cells in vitro, this amino acid was chosen for the present study in patients. Oral melphalan (4.5±0.5 mg/m2) was given to ten fasting patients with and without a 2-g oral dose of L-leucine on separate randomized occasions at least 1 week apart. Melphalan plasma levels were measured by high-performance liqu..
View full abstract